Multicenter , randomized , double-blind , placebo-controlled trial conducted in 3 Spanish teaching hospitals involving patients with both severe community-acquired pneumonia and a high inflammatory response , which was defined as a level of C-reactive protein greater than 150 mg/L at admission .